Evidence map›Paper›PMID 35784747›Full record

ArticleFrontiers in pharmacology2022

Fisetin Attenuated Oxidative Stress-Induced Cellular Damage in ARPE-19 Human Retinal Pigment Epithelial Cells Through Nrf2-Mediated Activation of Heme Oxygenase-1.

Cheol Park, Jeong Sook Noh, Youngmi Jung, Sun-Hee Leem, Jin Won Hyun, Young-Chae Chang, Taeg Kyu Kwon, Gi-Young Kim, Hyesook Lee, Yung Hyun Choi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Cheol ParkDivision of Basic Sciences, College of Liberal Studies, Dong-Eui University, Busan, South Korea.
Jeong Sook NohDepartment of Food Science and Nutrition, Tongmyong University, Busan, South Korea.
Youngmi JungDepartment of Integrated Biological Science, Pusan National University, Busan, South Korea.
Sun-Hee LeemDepartment of Biomedical Sciences, Dong-A University, Busan, South Korea.
Jin Won HyunDepartment of Biochemistry, College of Medicine, Jeju National University, Jeju, South Korea.
Young-Chae ChangResearch Institute of Biomedical Engineering and Department of Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea.
Taeg Kyu KwonDepartment of Immunology, School of Medicine, Keimyung University, Daegu, South Korea.
Gi-Young KimDepartment of Marine Life Science, Jeju National University, Jeju, South Korea.
Hyesook LeeDepartment of Convergence Medicine, Pusan National University School of Medicine, Yangsan, South Korea.
Yung Hyun ChoiAnti-Aging Research Center and Core-Facility Center for Tissue Regeneration, Dong-Eui University, Busan, South Korea.
Dong-Eui University · KRJeju National University · KRPusan National University · KRCatholic University of Daegu · KRDong-A University · KRKeimyung University · KRTongmyong University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fisetin is a kind of bioactive flavonol, widely present in various fruits such as strawberries and apples, and is known to act as a potent free radical scavenger. However, the mechanism of action related to the antioxidant activity of this compound in human retinal pigment epithelial (RPE) cells is not precisely known. In this study, we aimed to investigate whether fisetin could attenuate oxidative stress-induced cytotoxicity on human RPE ARPE-19 cells. To mimic oxidative stress, ARPE-19 cells were treated with hydrogen peroxide (H

Indexed as

apoptosisDNA damagefisetinhuman retinal pigment epithelial cellsNrf2/HO-1ROS

Identifiers

PMID35784747
PMCPMC9243462
OpenAlexW4283011588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.